Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia

References

• AbbottBLRubnitzJETongXClinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution’s experienceLeukemia200317112090209614523477
   PubMed Web of Science ®Google Scholar
• ReesJKGrayRGSwirskyDHayhoeFGPrincipal results of the Medical Research Council’s 8th acute myeloid leukaemia trialLancet (London, England)19862851812361241
   Web of Science ®Google Scholar
• CassilethPASylvesterLSBennettJMBeggCBHigh peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemiaJ Clin Oncol1988634954983162514
   PubMed Web of Science ®Google Scholar
• DöhnerHEsteyEHAmadoriSDiagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood2010115345347419880497
   PubMed Web of Science ®Google Scholar
• Bojsen-MøllerMNielsenJLCNS involvement in leukaemia. An autopsy study of 100 consecutive patientsActa Pathol Microbiol Immunol Scand A19839142092166575578
   PubMedGoogle Scholar
• StewartDJKeatingMJMcCredieKBNatural history of central nervous system acute leukemia in adultsCancer19814711841967459807
   PubMed Web of Science ®Google Scholar
• BakstRLTallmanMSDouerDYahalomJHow I treat extramedullary acute myeloid leukemiaBlood2011118143785379321795742
   PubMed Web of Science ®Google Scholar
• CastagnolaCNozzaACorsoABernasconiCThe value of combination therapy in adult acute myeloid leukemia with central nervous system involvementHaematologica19978255775809407724
   PubMed Web of Science ®Google Scholar
• MayadevJSDouglasJGStorerBEAppelbaumFRStorbRImpact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvementInt J Radiat Oncol Biol Phys201180119319820584584
   PubMed Web of Science ®Google Scholar
• SandersKEHaCSCortes-FrancoJEKollerCAKantarjianHMCoxJDThe role of craniospinal irradiation in adults with a central nervous system recurrence of leukemiaCancer2004100102176218015139061
   PubMed Web of Science ®Google Scholar
• BommerMvon HarsdorfSDöhnerHBunjesDRinghofferMNeoplastic meningitis in patients with acute myeloid leukemia scheduled for allogeneic hematopoietic stem cell transplantationHaematologica2010951119621972
   Web of Science ®Google Scholar
• FrickJTitchPSHansenRMSuccessful treatment of meningeal leukemia using systemic high dose cytosine arabinosideJ Clin Oncol198423653686726293
   PubMed Web of Science ®Google Scholar
• JohnstonDLAlonzoTAGerbingRBLangeBJWoodsWGRisk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemiaJ Clin Oncol200523369172917816361619
   PubMed Web of Science ®Google Scholar
• KobayashiRTawaAHanadaRExtramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemiaPediatr Blood Cancer200748439339816550530
   PubMed Web of Science ®Google Scholar
• PuiCHHowardSCCurrent management and challenges of malignant disease in the CNS in paediatric leukaemiaLancet Oncol20089325726818308251
   PubMed Web of Science ®Google Scholar
• SchaichMRölligCSoucekSCytarabine dose of 36 g/m2 compared with 12 g/m2 within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 studyJ Clin Oncol201129192696270221606413
   PubMed Web of Science ®Google Scholar
• RölligCThiedeCGramatzkiMA novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trialBlood2010116697197820442365
   PubMed Web of Science ®Google Scholar
• RölligCKramerMHanelMInduction treatment in elderly patients with acute myeloid leukemia (AML): randomized comparison of intermediate-dose cytarabine plus mitoxantrone (IMA) versus standard-dose cytarabine plus daunorubicin (DA) in 492 aml patients >60 years – resultsBlood201511621334
   Google Scholar
• ChesonBDBennettJMKopeckyKJRevised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJ Clin Oncol200321244642464914673054
   PubMed Web of Science ®Google Scholar
• OshimaKKandaYYamashitaTCentral nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantationBiol Blood Marrow Transplant200814101100110718804039
   PubMed Web of Science ®Google Scholar
• WoodsWGKobrinskyNBuckleyJIntensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot studyJ Clin Oncol1993118144814578336184
   PubMed Web of Science ®Google Scholar
• SimoneJVTreatment of meningeal leukemiaJ Clin Oncol1984253573586726292
   PubMed Web of Science ®Google Scholar
• SteinherzPJerebBGalicichJTherapy of CNS leukemia with intra-ventricular chemotherapy and low-dose neuraxis radiotherapyJ Clin Oncol198539121712263861774
   PubMed Web of Science ®Google Scholar
• GrierHEGelberRDCamittaBMPrognostic factors in childhood acute myelogenous leukemiaJ Clin Oncol198757102610323474356
   PubMed Web of Science ®Google Scholar
• ShihadehFReedVFaderlSCytogenetic profile of patients with acute myeloid leukemia and central nervous system diseaseCancer2012118111211721692072
   PubMed Web of Science ®Google Scholar
• Martínez-CuadrónDMontesinosPPérez-sirventMCentral nervous system involvement at first relapse in patients with acute myeloid leukemiaHaematologica20119691375137921565904
   PubMed Web of Science ®Google Scholar
• de BottonSSanzMAChevretSExtramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyLeukemia2006201354116307026
   PubMed Web of Science ®Google Scholar
• SpecchiaGLo CocoFVignettiMExtramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell’AdultoJ Clin Oncol200119204023402811600603
   PubMed Web of Science ®Google Scholar
• MorrisonFSKopeckyKJHeadDRLate intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia–results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and lLeukemia1992677087141625490
   PubMed Web of Science ®Google Scholar
• HolmesRKeatingMJCorkAA unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22)Blood1985655107110783857943
   PubMed Web of Science ®Google Scholar
• GhaddarHMPlunkettWKantarjianHMLong-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinosideLeukemia199488126912748057660
   PubMed Web of Science ®Google Scholar
• GrimwadeDHillsRKMoormanAVRefinement of cytogenetic classification in acute myeloid leukaemia: determination of prognostic significance of rarer recurring chromosomal abnormalities amongst 5,876 younger adult patients treated in the UK Medical Research Council trialsBr J Haematol2010116354365
   Google Scholar
• SorensenPHBChenCSSmithFOMolecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypesJ Clin Invest19949314294378282816
   PubMed Web of Science ®Google Scholar
• ChangHBrandweinJYiQ-LChunKPattersonBBrienBExtramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcomeLeuk Res200428101007101115289011
   PubMed Web of Science ®Google Scholar